Effect of rituximab on heart involvement in systemic sclerosis

Por L. A. Garzanova, L. P. Ananyeva, O. A. Koneva, O. B. Ovsyannikova
Publicado em 2019-01-01

Interstitial lung disease in systemic sclerosis (systemic scleroderma)

Por L. P. Ananyeva, I. E. Tyurin, O. A. Koneva, L. A. Garzanova, A. M. Lila
Publicado em 2021-03-01

Bone mineral density in patients with systemic scleroderma

Por O. V. Dobrovolskaya, N. V. Demin, A. V. Smirnov, L. A. Garzanova, N. V. Toroptsova, R. T. Alekperov
Publicado em 2019-03-01

Clinical and laboratory characteristics of patients with systemic sclerosis positive for anti-ribonucleoprotein antibodies

Por R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N. Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova
Publicado em 2019-11-01

Immunological features in anti-U1-ribonucleoprotein antibody positive patients with systemic scleroderma

Por R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova
Publicado em 2020-03-01

Short-term absolute B-cell counts monitoring in systemic sclerosis patients treated with rituximab

Por L. P. Ananieva, L. A. Garzanova, O. V. Desinova, O. A. Koneva, M. N. Starovoytova, O. B. Ovsyannikova, A. P. Aleksankn, S. I. Glukhova
Publicado em 2020-09-01

Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 2. Safety and complications

Por O. B. Ovsyannikova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. V. Desinova, R. U. Shayakhmetova, M. N. Starovoitova, A. M. Lila
Publicado em 2021-02-01

Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 1. Clinical aspects

Por O. B. Ovsyannikova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, R. U. Shayakhmetova, O. V. Desinova, M. N. Starovoitova, A. M. Lila
Publicado em 2020-11-01

Comparative characteristics of the main phenotypes of systemic sclerosis

Por R. U. Shayakhmetova, L. P. Ananyeva, M. N. Starovoitova, O. V. Desinova, O. A. Koneva, O. B. Ovsyannikova, L. A. Garzanova, M. V. Cherkasova, R. T. Alekperov
Publicado em 2020-02-01

Effect of rituximab on the manifestations of activity and pulmonary function in patients with systemic sclerosis: one-year follow-up evaluation

Por L. P. Ananyeva, O. A. Koneva, O. V. Desinova, L. A. Garzanova, S. I. Glukhova, M. N. Starovoitova, O. B. Ovsyannikova, A. V. Volkov, A. P. Aleksankin, E. L. Nasonov
Publicado em 2019-07-01

Anti-topoisomerase 1 antibody level changes after B сell depletion therapy in systemic sclerosis

Por L. P. Ananyeva, L. A. Garzanova, O. A. Koneva, M. N. Starovoytova, O. V. Desinova, O. B. Ovsyannikova, R. U. Shayakhmetova, M. V. Cherkasova, A. P. Aleksankin, E. L. Nasonov
Publicado em 2022-03-01